Evidence map›Paper›PMID 32556127›Full record

ArticleChemical senses2020

Identifying Treatments for Taste and Smell Disorders: Gaps and Opportunities.

Joel D Mainland, Linda A Barlow, Steven D Munger, Sarah E Millar, M Natalia Vergara, Peihua Jiang, James E Schwob, Bradley J Goldstein, Shannon E Boye, Jeffrey R Martens and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Chemical senses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
2.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Taste and Smell Alterations (TSAs) in Cancer Patients.Diseases (Basel, Switzerland) · 2024
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Olfactory Function and Olfactory Disorders.Laryngo- rhino- otologie · 2023
    Article
  17. Article
  18. Olfactory Dysfunction: Etiology, Diagnosis, and Treatment.Deutsches Arzteblatt international · 2023
    Review
  19. Review
  20. Establishing UK research priorities in smell and taste disorders: A James Lind alliance priority setting partnership.Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 12 institutions in 2 countries.

Joel D MainlandMonell Chemical Senses Center, Philadelphia, PA, USA.
Linda A BarlowDepartment of Cell & Developmental Biology, Rocky Mountain Taste and Smell Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Steven D MungerCenter for Smell and Taste, Department of Pharmacology and Therapeutics, 1200 Newell Drive, University of Florida, Gainesville, FL, USA.
Sarah E MillarBlack Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
M Natalia VergaraDepartment of Ophthalmology, Sue Anschutz-Rodgers Eye Center, University of Colorado School of Medicine, Aurora, CO, USA.
Peihua JiangMonell Chemical Senses Center, Philadelphia, PA, USA.
James E SchwobDepartment of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, MA, USA.
Bradley J GoldsteinDepartment of Head and Neck Surgery and Communication Sciences, Duke University School of Medicine, 40 Duke Medicine Cir Clinic 1F, Durham, NC, USA.
Shannon E BoyeDepartment of Ophthalmology, University of Florida College of Medicine, Gainesville, FL, USA.
Jeffrey R MartensCenter for Smell and Taste, Department of Pharmacology and Therapeutics, 1200 Newell Drive, University of Florida, Gainesville, FL, USA.
Donald A LeopoldDivision of Otolaryngology Head and Neck Surgery, University of Vermont Medical Center, Burlington, VT, USA.
Linda M BartoshukDepartment of Food Science and Human Nutrition, Center for Smell and Taste, University of Florida, Gainesville, FL, USA.
Richard L DotySmell and Taste Center and Department of Otorhinolaryngology: Head and Neck Surgery, Perelman School of Medicine, 3400 Spruce Street, University of Pennsylvania, Philadelphia, PA, USA.
Thomas HummelDepartment of Otorhinolaryngology, Smell and Taste Clinic, Technische Universität Dresden, Fetscherstrasse, Dresden, Germany.
Jayant M PintoSection of Otolaryngology-Head and Neck Surgery, Department of Surgery, The University of Chicago, MC, Chicago, IL, USA.
Casey TrimmerFirmenich Inc., Plainsboro, NJ, USA.
Christine KellyAbScent, Andover, Hampshire, UK.
Edmund A PribitkinDepartment of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
Danielle R ReedMonell Chemical Senses Center, Philadelphia, PA, USA.
University of Florida · USMonell Chemical Senses Center · USDuke University · USFirmenich (United States) · USIcahn School of Medicine at Mount Sinai · USRocky Mountain MS Center · USTaste and Smell Clinic · USTechnische Universität Dresden · DEThomas Jefferson University · USTufts University · USUniversity of Chicago · USUniversity of Vermont Medical Center · US

Funding

Engineering AAV for safe and efficient gene delivery to the human retinaR01EY024280 · NEI · UNIVERSITY OF FLORIDA · PI Shannon Elizabeth Boye · 2014 to 2026
$7.5M
INTERDISCIPLINARY TRAINING IN THE CHEMICAL SENSEST32DC000014 · NIDCD · MONELL CHEMICAL SENSES CENTER · PI PAMELA HELEN DALTON, Joel D Mainland · 1989 to 2026
$6.2M
Mechanisms of Adult Taste Bud RegenerationR01DC012383 · NIDCD · UNIVERSITY OF COLORADO DENVER · PI BARLOW, LINDA A · 2012 to 2021
$3.4M
DEVELOPMENT OF AAV-CRISPR/CAS9-BASED THERAPIES FOR CONE ROD DYSTROPHYR01EY028968 · NEI · UNIVERSITY OF FLORIDA · PI BOYE, SHANNON ELIZABETH, GAMLIN, PAUL DOUGLAS · 2019 to 2022
$2.2M
SCENTinel: A Rapid Smell Test for COVID-19 SurveillanceU01DC019578 · NIDCD · MONELL CHEMICAL SENSES CENTER · PI DALTON, PAMELA HELEN, PARMA, VALENTINA · 2021 to 2023
$1.2M
Emerging Strategies for Treating Chemosensory DisordersR13DC017387 · NIDCD · MONELL CHEMICAL SENSES CENTER · PI BARLOW, LINDA A, MAINLAND, JOEL D · 2018 to 2018
$40k
NEI NIH HHS R01 EY024280NEI NIH HHS R01 EY028968NIDCD NIH HHS R01 DC012383NIDCD NIH HHS R13 DC017387NIDCD NIH HHS T32 DC000014NIDCD NIH HHS U01 DC019578
6 · The paper itself

Abstract

The chemical senses of taste and smell play a vital role in conveying information about ourselves and our environment. Tastes and smells can warn against danger and also contribute to the daily enjoyment of food, friends and family, and our surroundings. Over 12% of the US population is estimated to experience taste and smell (chemosensory) dysfunction. Yet, despite this high prevalence, long-term, effective treatments for these disorders have been largely elusive. Clinical successes in other sensory systems, including hearing and vision, have led to new hope for developments in the treatment of chemosensory disorders. To accelerate cures, we convened the "Identifying Treatments for Taste and Smell Disorders" conference, bringing together basic and translational sensory scientists, health care professionals, and patients to identify gaps in our current understanding of chemosensory dysfunction and next steps in a broad-based research strategy. Their suggestions for high-yield next steps were focused in 3 areas: increasing awareness and research capacity (e.g., patient advocacy), developing and enhancing clinical measures of taste and smell, and supporting new avenues of research into cellular and therapeutic approaches (e.g., developing human chemosensory cell lines, stem cells, and gene therapy approaches). These long-term strategies led to specific suggestions for immediate research priorities that focus on expanding our understanding of specific responses of chemosensory cells and developing valuable assays to identify and document cell development, regeneration, and function. Addressing these high-priority areas should accelerate the development of novel and effective treatments for taste and smell disorders.

Indexed as

Congresses as TopicGenetic TherapyHumansOlfaction DisordersRegenerative MedicineSmall Molecule LibrariesStem CellsStem Cell TransplantationTaste DisordersSmall Molecule Librariescell cultureolfactionsniff

Identifiers

PMID32556127
PMCPMC7545248
OpenAlexW3035775099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.